Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma

Mazzaferro, V; El-Rayes, BF; Busset, MDD; Cotsoglou, C; Harris, WP; Damjanov, N; Masi, G; Rimassa, L; Personeni, N; Braiteh, F; Zagonel, V; Papadopoulos, KP; Hall, T; Wang, YX; Schwartz, B; Kazakin, J; Bhoori, S; de Braud, F; Shaib, WL

Mazzaferro, V (reprint author), Ist Nazl Tumori IRCCS, Dept Surg & Oncol, Milan, Italy.; Mazzaferro, V (reprint author), Univ Milan, Milan, Italy.; El-Rayes, BF (reprint author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.

BRITISH JOURNAL OF CANCER, 2019; 120 (2): 165

Abstract

BACKGROUND: Next-generation sequencing has identified actionable genetic aberrations in intrahepatic cholangiocarcinomas (iCCA), including the fibrobl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索